Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20193514 20169945 null null Adjuvant (A) 2019-07-15 2019-07-25 null 02 N CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED 100967649
20193552 20169946 1.69 104 03 2019-12-02 2019-12-08 MIC 02 N ECF 100636346
20193638 20169947 1.79 59.55 null 2019-02-28 2019-12-23 SCOPE 2 TRIAL 02 N CARFILZOMIB 101825471
20193764 20169948 1.7 60 null 2018-08-08 2018-08-08 CHOP R - 21 days 99 null MELPHALAN 100878145
20193816 20169949 1.97 65.2 Palliative (P) 2019-11-21 2019-11-22 FOCUS4 TRIAL 02 N VINORELBINE 100567206
20194172 20169950 null null Palliative (P) 2017-12-23 2017-12-26 Binimetinib + Encorafenib 02 null CISPLATIN + FLUOROURACIL + RT 100352389
20194445 20169951 1.84 69.9 Palliative (P) 2018-02-04 2018-02-05 Gemcitabine + Oxaliplatin 02 N CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE 100408192
20194533 20169952 1.49 125.2 Neo-adjuvant (N) 2016-12-13 2017-12-05 CARBOPLATIN + FLUOROURACIL + Trastuzumab 02 N CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE 100062470
20194746 20169953 1.77 76.8 Curative (C) 2016-01-22 2016-12-02 CAM-PLEX Trial 02 null PACLITAXEL + RAMUCIRUMAB 101348927
20194882 20169954 1.8 64 null 2020-07-05 2020-07-11 Durvalumab 02 null CAV 100175880
20195081 20169955 null 22.8 Disease modification (D) null 2019-03-29 CT7001 null Y BACILLUS CALMETTE-GUERIN 100873840
20195682 20169956 null 17.2 03 2018-06-18 2018-06-30 EEF or EOF 02 null CARBOPLATIN + RALTITREXED 100723794
20197298 20169957 1.58 59 Neo-adjuvant (N) 2020-06-29 2020-06-29 BENDAMUSTINE + RITUXIMAB N N CAPECITABINE + STREPTOZOCIN 101227674
20197652 20169958 1.86 62.2 null 2018-06-03 2018-08-04 IBRUTINIB 02 N TEMOZOLOMIDE 101151692
20197694 20169959 1.83 69.2 null 2018-12-22 2020-04-25 CAV 02 N CNS ATRT VCA VINC/DACTINO/CYCLOPHOS 100150951
20197771 20169960 1.75 19.5 Palliative (P) 2019-07-28 2019-08-04 Epirubicin 02 null BACILLUS CALMETTE-GUERIN 101740973
20198126 20169961 1.53 55.1 Adjuvant (A) 2017-05-08 2021-01-02 Paclitaxel albumin (Abraxane) 21day N N ERIBULIN 100341536
20198192 20169962 1.54 53.4 Palliative (P) 2019-10-28 2019-10-28 OXALIPLATIN + MDG + PANITUMUMAB 02 N OXALIPLATIN + MDG + PANITUMUMAB 100980667
20198502 20169963 1.76 115.9 null 2018-05-18 2018-05-24 CAM-PLEX Trial 02 null ECARBOX 100826449
20198916 20169964 0 65.2 null 2021-08-10 2021-08-17 R-CHOEP 02 null SCOPE 1 TRIAL 100498854
20199648 20169965 1.5 null 03 2017-03-10 2020-02-05 CYCLOPHOSPHAMIDE + THALIDOMIDE 02 N FLUOROURACIL + OXALIPLATIN + TRASTUZUMAB 100122884
20199729 20169966 2 87.4 03 2020-06-09 2020-06-28 MELPHALAN null N LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) 100995507
20200205 20169967 1.72 115.9 null 2020-11-06 2020-11-06 Carboplatin + Fluorouracil + Streptozocin 02 null ECARBOX 100355560
20200367 20169968 1.72 78.1 null 2016-08-16 2016-08-16 Olaparib 02 null TOPOTECAN 101569823
20200379 20169969 1.7 109 null 2022-02-26 2022-03-26 CAV 01 N CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE 101544874
20200823 20169970 1.81 77.6 Palliative (P) 2018-10-26 2018-11-06 OXALIPLATIN + MDG + PANITUMUMAB 02 N CISPLATIN + RT 100337471
20201166 20169971 null null Palliative (P) 2018-10-10 2018-11-25 Bortezomib + Daratumumab 02 N BUSULPHAN 100687744
20201314 20169972 1.6 81.55 Palliative (P) 2018-09-20 2018-09-22 CAPECITABINE + MITOMYCIN + RT 02 N CISPLATIN + FLUOROURACIL + RT 101256435
20201351 20169973 1.71 118.6 Disease modification (D) 2020-04-08 2020-05-06 FCarboSt 02 N CARBOPLATIN + LIPOSOMAL DOXORUBICIN 100065020
20201824 20169974 1.42 56.1 null 2018-10-14 2018-10-17 FLUOROURACIL + OXALIPLATIN + Trastuzumab 02 N BEVACIZUMAB + FLUOROURACIL + IRINOTECAN 100763172
20202435 20169976 1.71 57 Neo-adjuvant (N) 2021-05-17 2021-06-29 Temozolomide + RT 02 N DOCETAXEL + GEMCITABINE 101699061
20202543 20169977 1.58 81.7 Neo-adjuvant (N) 2018-02-03 2018-02-03 Carboplatin + Liposomal Doxorubicin 02 null ETOPOSIDE 100765754
20202716 20169978 1.89 75.5 null 2021-03-24 2021-03-24 Rituximab 02 null TCH 100129577
20203204 20169980 0 64.15 Neo-adjuvant (N) 2021-01-26 2021-02-02 Capecitabine + Streptozocin N N OBINUTUZUMAB 101602500
20203627 20169981 1.71 75.9 null 2022-01-13 2022-01-19 SCOPE 2 TRIAL 02 N CABOZANTINIB 101042890
20203679 20169982 1.52 85 null 2020-01-06 2020-01-09 Brentuximab 02 null CARBOPLATIN + VINORELBINE 101039595
20203844 20169983 1.8 null null 2022-02-01 2022-03-01 TEMOZOLOMIDE 02 N DABRAFENIB + TRAMETINIB 100156914
20204002 20169984 1.69 95.65 null 2019-07-01 2019-12-26 R GCVP 02 null GEMCITABINE + OXALIPLATIN 101176113
20204380 20169986 1.58 62.4 null 2019-11-04 2019-11-05 Rituximab 02 null CAPE + OXALIPLATIN + TRASTUZUMAB 100099922
20204408 20169987 null null Palliative (P) 2017-05-21 2018-04-21 FCarboSt N N CISPLATIN + PEMETREXED 101403143
20204423 20169988 1.71 71.6 03 2021-07-09 2021-07-09 CAPECITABINE + LOMUSTINE 02 N TOPOTECAN 100383333
20204510 20169990 1.77 63.8 Palliative (P) 2021-09-21 2021-11-02 Cisplatin +FU +Trastuzumab - Load 02 null CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 101478155
20204955 20169991 1.6 86.5 02 null 2022-05-16 CHOP R - 21 days null N DOXORUBICIN 100856300
20205252 20169992 1.6 null Curative (C) 2021-06-15 2021-06-26 CAP + RT 2 N CAPECITABINE + STREPTOZOCIN 101853630
20205393 20169993 1.65 68.5 Palliative (P) 2019-09-10 2019-11-25 Capecitabine + Streptozocin 02 N CYTARABINE 100502456
20205425 20169994 0.7 null Palliative (P) 2016-08-07 2016-12-16 Cisplatin +FU +Trastuzumab - Maint 02 N FLUOROURACIL + RT 101035569
20205674 20169995 1.98 46 Curative (C) 2019-11-28 2019-12-30 Doxorubicin + Olaratumab 02 N CAPECITABINE + OXALIPLATIN + TRASTUZUMAB 101791858
20205829 20169997 1.55 56.2 Palliative (P) 2016-11-10 2019-02-11 FLUOROURACIL + Panitumumab N Y DOCETAXEL + PERTUZUMAB + TRASTUZUMAB 101085882
20206048 20169999 1.71 null 03 2019-11-28 2019-11-29 Temozolomide + RT 99 N CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED 101257517
20206119 20170000 1.77 71.1 Palliative (P) null 2018-01-23 CAP + RT 1 null CISPLATIN + RT 100637538